- Training
- October 2025
- 2 Days
Global
From €1386EUR$1,558USD£1,216GBP
- Training
- June 2026
- 2 Days
Global
€1532EUR$1,782USD£1,299GBP
€1767EUR$2,056USD£1,499GBP
- Report
- October 2025
- 193 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- October 2025
- 191 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- October 2025
- 199 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- October 2025
- 195 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- October 2025
- 186 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- October 2025
- 191 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- August 2025
- 180 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- August 2025
- 181 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- August 2025
- 191 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- August 2025
- 195 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- August 2025
- 193 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- August 2025
- 198 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- August 2025
- 197 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- August 2025
- 185 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- August 2025
- 182 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- August 2025
- 188 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- August 2025
- 198 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP
- Report
- August 2025
- 184 Pages
Global
From €3154EUR$3,545USD£2,769GBP
€3505EUR$3,939USD£3,076GBP

Process Validation is a critical component of pharmaceutical manufacturing, ensuring that the processes used to produce a drug are consistently reliable and reproducible. It involves a series of activities that demonstrate that a process is capable of consistently delivering a product meeting its predetermined specifications and quality attributes. This includes the development of a process design, the establishment of process performance criteria, and the collection and evaluation of data to demonstrate that the process is capable of consistently producing a product meeting its predetermined specifications and quality attributes. Process Validation also includes the establishment of process control strategies, such as process monitoring and corrective action plans.
Companies in the Process Validation market include Merck, Pfizer, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, AbbVie, and Eli Lilly. Show Less Read more